Amplatzer Amulet LAAO vs. NOAC
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 2650 participants.
Also called NCT04226547
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,650 participants
- Sponsor
- Registry
-
NCT04226547
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Canada, Czechia, Denmark, France, Germany, Hong Kong SAR China, Italy, Japan, Lithuania, Netherlands, Poland, Spain, Switzerland, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04226547. Randomized; single masking; primary purpose treatment. Start 2020-07-07 (actual); primary completion 2029-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Amplatzer Amulet LAAO vs. NOAC
- Acronym
- CATALYST
- Condition
- Atrial Fibrillation
- Condition
- Stroke
- Condition
- Bleeding
- Intervention (Device)
- Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder)
- Intervention (Drug)
- Non-Vitamin K Oral Antagonists
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct04226547- Content hash
6572d0c9912b76049398f9ec99157dc12475a88a59f00357fa0f396e21536f76